Identification of a Novel Regulatory Region Critical for Expression of the RANTES Chemokine in Activated T Lymphocytes

Journal of Immunology

Volumn 157, Issue 3, 1996, Pages 1139-1148

  Nelson, Peter J ^a,b   Ortiz, Benjamin D ^b   Pattison, James M ^b,c   Krensky, Alan M ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL KIDNEY FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DNA; LUCIFERASE; RANTES;

ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; DNA FOOTPRINTING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPHOCYTE ACTIVATION; METABOLISM; METHYLATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REPORTER GENE; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE;

BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; DEOXYRIBONUCLEASE I; DNA; DNA FOOTPRINTING; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; LYMPHOCYTE ACTIVATION; METHYLATION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); RANTES; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0030209768     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Schall, T. J. 1994. The chemokines. In The Cytokine Handbook, 2nd Ed. A Thomson, ed. Academic Press, New York, p. 419.
2. Nelson, P. J., J. M. Pattison, and A. M. Krensky. 1996. Biology and pathophisiology of the RANTES chemokine. In Chemoattractant Ligands and Their Receptors. R. Horuk, ed. CRC Press, Boca Raton, FL, pp. 145-168.
3. Schall, T. J., J. Jongstra, B. J. Bradley, J. Dyer, J. Jorgensen, C. Clayberger, M. Davis, and A. M. Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141:1018.
4. + T cells. Science 270:1560.
5. Kameyoshi, Y., A. Dorschner, A. I. Mallet, E. Chrisophers, and J.-M. Schroder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176:587.
6. Kuna, P., S. R. Reddigari, T. J. Schall, D. Rucinski, M. Y. Viksman, and A. P. Kaplan. 1992. RANTES, A monocyle and T lymphocyte chemotactic cytokine releases histamine from human basophils. J. Immunol. 149:636.
7. Schall, T. J., K. Bacon, K. J. Toy, and D. V. Goeddel. 1990. Selective attraction of monocytes and T lymphocyles of the memory phenotype by cytokine RANTES. Nature 347:667.
8. + T cells in response to MIP-1 alpha and MIP-1 beta. Science 260:356.
9. Maghazachi, A. A., A. al-Aoukaty, and T. J. Schall. 1994. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells: role for G proteins. J. Immunol. 153:4969.
10. Taub, D. D., T. J. Sayers, C. R. Carter, and J. R. Ortaldo. 1995. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877.
11. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269:1727.
12. Levy, J. 1993. HIV pathogenesis and long-term survival. AIDS 7:1401.
13. Haynes, B. F., G. Pantaleo, and A. S. Fauci. 1996. Toward an understanding of the correlates of protective immunity to HIV infection. Science 271:324.
14. Ortiz, B. D., A. M. Krensky, and P. J. Nelson. 1995. Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T lymphocyte maturation. Mol. Cell. Biol. 16:202.
15. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activtion. Science 243:355.
16. Nelson, P. J., H. T. Kim, W. C. Manning, T. J. Goralski, and A. M. Krensky. 1993. Genomic organization and transcriptional regulation of the RANTES cytokine gene. J. Immunol. 151:2601.
17. Clayberger, C., N. Holmes, P. L. Wang, T. D. Koller, P. Parham, and A. M. Krensky. 1985. Determinants recognized by human cytotoxic T cells on a natural hybrid class I HLA molecule. J. Exp. Med 162:1709.
18. Wright, A., J. W. Lee, M. P. Link, S. D. Smith, W. Carroll, R. Levy, C. Clayberger, and A. M. Krensky. 1989. Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor gamma chain. J. Exp. Med. 169:1557.
19. Spaete, R. R., and E. S. Mocarski. 1985. Regulation of cytomegalovirus gene expression: α and β promoters are trans activated by viral functions in permissive human fibroblasts. J. Virol. 56:135.
20. Scharf, S. J. 1990. Cloning with PCR. In PCR Protocols: A Guide to Methods and Applications. M. A. Innis, D. H. Gelfand, J. J. Sininsky, and T. J. White, eds. Academic Press, Orlando, FL p. 84.
21. Hall, C. V., P. E. Jacob, G. M. Ringold, and F. Lee. 1983. Expression and regulation of Escherichia coli lac Z gene fusions in mammalian cells. J. Mol. Appl. Gen. 2:101.
22. Durand D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715.
23. Jones K. A., K. R. Yamamoto, and R. Tjian. 1985. Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell 42:559.
24. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Strunl. 1987. Mobility shift DNA-binding assay using gel electrophoresis. In Current Protocols in Molecular Biology. Green Publishing Associates and Wiley-Interscience, New York, p. 12.2.1.
25. Baldwin, A. S., Jr., and P. A. Sharp. 1988. Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc. Natl. Acad. Sci. USA 85:723.
26. Gootenberg, J. E., F. W. Ruscetti, J. W. Mier, A. Gazdar, and R. C. Gallo. 1981. Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J. Exp. Med 154:1403.
27. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. Role of T3 surface molecules in the activation of human T cells: a two stimulus requirement for IL-2 production reflects events occurring at a pretranslational level. J. Immunol. 133:123.
28. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
29. Mauviel, A., S. Reitamo, A. Remitz, J. C. Lapiere, M. Ceska, M. Baggiolini, A. Walz, C. H. Evans, and J. Uitto. 1992. Leukoregulin, a T cell-derived cytokine, induces IL-8 gene expression and secretion in human skin fibroblasts: demonstration of enhanced NF-κB binding and NF-κB-driven promoter activity. J. Immunol. 149:2969.
30. Ullman, K. S., J. P. Northrop, C. L. Verweij, and G. R. Crabtree. 1990. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function. Annu. Rev. Immunol. 8:421.
31. + T-lymphocytes. Science 256:1452.
32. Nolan, G. P. 1994. NF-AT-AP-1 and Rel-bZIP hybrid vigor and binding under the influence. Cell 77:795.
33. Northrop, J. P., S. N. Ho, L. Chen, D. J. Thomas, L. A. Timmerman, G. P. Nolan, A. Admon, and G. R. Crabtree. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369:497.
34. Rao, A. 1994. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15:274.
35. Stein, B., and A. S. Baldwin, Jr., 1993. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NK-kappaB. Mol. Cell. Biol. 13:7191.
36. Wasylyk, C., A. Gutman, R. Nickolson, and B. Wasylyk. 1991. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J. 10:1127.
37. Ullman, K. S., W. M. Flanagan, C. A. Edwards, and G. R. Crabtree. 1991. Activation of early gene expression in T-lymphocytes by Oct-1 and an inducible protein OAP40. Science 254:558.
38. Thanos, D., and T. Maniatis. 1992. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71:777.
39. Pattison, J. M., P. J. Nelson, and A. M. Krensky. 1995. Pathophysiology of the RANTES chemokine: a new target for immunomodulatory therapy? Clin. Immunother. 3:1.